A Mattei

875 total citations
28 papers, 609 citations indexed

About

A Mattei is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Reproductive Medicine. According to data from OpenAlex, A Mattei has authored 28 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 7 papers in Reproductive Medicine. Recurrent topics in A Mattei's work include Pituitary Gland Disorders and Treatments (16 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Adrenal and Paraganglionic Tumors (10 papers). A Mattei is often cited by papers focused on Pituitary Gland Disorders and Treatments (16 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Adrenal and Paraganglionic Tumors (10 papers). A Mattei collaborates with scholars based in Italy, Belgium and United Kingdom. A Mattei's co-authors include Pier Giorgio Crosignani, Carlo Ferrari, A. Paracchi, R. John Aitken, Stewart Irvine, A D’Alberton, R Roulier, P Franchimont, Giovanni Ferrari and P.M. Kićović and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the New York Academy of Sciences and American Journal of Obstetrics and Gynecology.

In The Last Decade

A Mattei

28 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Mattei Italy 13 434 204 134 61 52 28 609
K. O. NILSSON Sweden 14 359 0.8× 229 1.1× 43 0.3× 21 0.3× 181 3.5× 31 766
Roger E. Johnsonbaugh United States 13 234 0.5× 82 0.4× 110 0.8× 27 0.4× 194 3.7× 34 610
W. Sorgo Germany 14 223 0.5× 107 0.5× 76 0.6× 60 1.0× 121 2.3× 28 478
Judith Brownell Netherlands 15 382 0.9× 218 1.1× 44 0.3× 8 0.1× 66 1.3× 31 540
H L Lenko Finland 12 293 0.7× 187 0.9× 98 0.7× 37 0.6× 245 4.7× 19 616
P Polosa Italy 12 283 0.7× 40 0.2× 211 1.6× 77 1.3× 133 2.6× 40 529
H.G. Dahlén Germany 10 175 0.4× 39 0.2× 178 1.3× 56 0.9× 79 1.5× 22 385
R Jewelewicz United States 12 92 0.2× 60 0.3× 218 1.6× 180 3.0× 30 0.6× 29 521
J. L. Vandalem Belgium 10 261 0.6× 29 0.1× 101 0.8× 24 0.4× 74 1.4× 14 389
I. Stavrou Greece 8 239 0.6× 49 0.2× 110 0.8× 46 0.8× 106 2.0× 10 573

Countries citing papers authored by A Mattei

Since Specialization
Citations

This map shows the geographic impact of A Mattei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Mattei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Mattei more than expected).

Fields of papers citing papers by A Mattei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Mattei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Mattei. The network helps show where A Mattei may publish in the future.

Co-authorship network of co-authors of A Mattei

This figure shows the co-authorship network connecting the top 25 collaborators of A Mattei. A scholar is included among the top collaborators of A Mattei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Mattei. A Mattei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crosignani, P.G., A Mattei, Paola Maggioni, Giovanna Testa, & Eva Negri. (1994). Efficacy of Placebo in the Treatment of Patients with Amenorrhea. Gynecologic and Obstetric Investigation. 37(3). 183–184. 3 indexed citations
2.
Crosignani, Pier Giorgio, et al.. (1992). Long-term effects of time, medical treatment and pregnancy in 176 hyperprolactinemic women. European Journal of Obstetrics & Gynecology and Reproductive Biology. 44(3). 175–180. 54 indexed citations
3.
Ferrari, Giovanni, et al.. (1992). Cabergoline in the long-term therapy of hyperprolactinemic disorders. European Journal of Endocrinology. 126(6). 489–494. 90 indexed citations
4.
Mattei, A, et al.. (1991). Natural History of Hyperprolactinemia. Annals of the New York Academy of Sciences. 626(1). 130–136. 3 indexed citations
5.
Crosignani, Pier Giorgio, et al.. (1989). Is pregnancy the best treatment for hyperprolactinaemia?. Human Reproduction. 4(8). 910–912. 29 indexed citations
6.
Ferrari, Carlo, A Mattei, Gian Benedetto Melis, et al.. (1989). Cabergoline: Long-Acting Oral Treatment of Hyperprolactinemic Disorders. The Journal of Clinical Endocrinology & Metabolism. 68(6). 1201–1206. 47 indexed citations
7.
Mattei, A, Carlo Ferrari, Paolo Baroldi, et al.. (1988). Prolactin-Lowering Effect of Acute and Once Weekly Repetitive Oral Administration of Cabergoline at Two Dose Levels in Hyperprolactinemic Patients. The Journal of Clinical Endocrinology & Metabolism. 66(1). 193–198. 41 indexed citations
8.
Aitken, R. John, A Mattei, & Stewart Irvine. (1986). Paradoxical stimulation of human sperm motility by 2-deoxyadenosine. Reproduction. 78(2). 515–527. 69 indexed citations
9.
Scarduelli, C., et al.. (1985). Effect of Fenfluramine Oral Administration on Serum Prolactin Levels in Healthy and Hyperprolactinemic Women. Gynecologic and Obstetric Investigation. 19(2). 92–96. 7 indexed citations
10.
Mattei, A, Carlo Ferrari, G. Ragni, et al.. (1984). Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline. BJOG An International Journal of Obstetrics & Gynaecology. 91(3). 244–250. 11 indexed citations
11.
Crosignani, PierGiorgio, et al.. (1984). Visual field defects and reduced visual acuity during pregnancy in two patients with prolactinoma: rapid regression of symptoms under bromocriptine. Case reports. BJOG An International Journal of Obstetrics & Gynaecology. 91(8). 821–823. 18 indexed citations
12.
Crosignani, Pier Giorgio, Carlo Ferrari, Antonio Liuzzi, et al.. (1982). Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride. Fertility and Sterility. 37(1). 61–67. 33 indexed citations
13.
Farthing, M.J.G., A Mattei, Christopher R.W. Edwards, & A M Dawson. (1982). Relationship between plasma testosterone and dihydrotestosterone concentrations and male facial hair growth. British Journal of Dermatology. 107(5). 559–564. 36 indexed citations
14.
Crosignani, P.G., A Mattei, Carlo Ferrari, & Massimo Giovanelli. (1982). Enlargement of a prolactin‐secreting pituitary microadenoma during bromocriptine treatment. BJOG An International Journal of Obstetrics & Gynaecology. 89(2). 169–170. 12 indexed citations
15.
16.
Ferrari, Carlo, P. Travaglini, Roberto Caldara, et al.. (1979). Restoration of the Prolactin Response to Sulpiride by Metergoline Administration in Hyperprolactinemic Patients. Neuroendocrinology. 29(5). 338–345. 1 indexed citations
17.
Crosignani, Pier Giorgio, Carlo Ferrari, A Mattei, et al.. (1979). Metergoline Treatment of Hyperprolactinemic States. Fertility and Sterility. 32(3). 280–285. 3 indexed citations
18.
Franchimont, P, P.M. Kićović, A Mattei, & R Roulier. (1978). EFFECTS OF ORAL TESTOSTERONE UNDECANOATE IN HYPOGONADAL MALE PATIENTS*. Clinical Endocrinology. 9(4). 313–320. 49 indexed citations
19.
Crosignani, Pier Giorgio, et al.. (1978). Antiserotonin treatment of hyperprolactinemic amenorrhea: Long-term follow-up with metergoline, methysergide, and cyproheptadine. American Journal of Obstetrics and Gynecology. 132(3). 307–312. 9 indexed citations
20.
Crosignani, Pier Giorgio, Eugenio Reschini, & A Mattei. (1977). Dopamine agonists and serotonin antagonists in the management of hyperprolactinemic states. 8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. O. NILSSON Breakdown of academic impact, for papers by Roger E. Johnsonbaugh Breakdown of academic impact, for papers by W. Sorgo Breakdown of academic impact, for papers by Judith Brownell Breakdown of academic impact, for papers by H L Lenko Breakdown of academic impact, for papers by P Polosa Breakdown of academic impact, for papers by H.G. Dahlén Breakdown of academic impact, for papers by R Jewelewicz Breakdown of academic impact, for papers by J. L. Vandalem Breakdown of academic impact, for papers by I. Stavrou
Rankless by CCL
2026